Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Progressive sensorineural hearing impairment, Ptosis, Low muscle tone (hypotonia), and Reduced tendon reflexes and others. 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 5 | Myopathy, Low muscle tone (hypotonia), Reduced tendon reflexes |
Eyes | 4 | Cataract, Developmental cataract, Ptosis |
Ears | 2 | Inner ear hearing loss (sensorineural hearing impairment), Progressive sensorineural hearing impairment |
Brain and nerves | 1 | Global developmental delay |
Lungs and breathing | 1 | Decreased activity of mitochondrial respiratory chain |
Lab test results | 1 | Decreased activity of mitochondrial respiratory chain |
GFER encodes growth factor, augmenter of liver regeneration (205 aa). FAD-dependent sulfhydryl oxidase that regenerates the redox-active disulfide bonds in CHCHD4/MIA40, a chaperone essential for disulfide bond formation and protein folding in the mitochondrial intermembrane space. Highest expression in Brain Cerebellum (39.4 TPM) and Brain Cerebellar Hemisphere (39.0 TPM).
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome is associated with mutations in the GFER gene on chromosome 16.
The GFER protein participates in MIA40:ERV1 (CHCHD4:GFER) oxidizes cysteine residues to cystine disulfide bonds pathway.
GFER is classified as a druggable target (Druggable Genome, Enzyme, and Growth Factor categories) with score 1.2.
Genetic testing for GFER is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 10 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 2:29 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome